Aster DM Healthcare files Reg 29(2) disclosure on share acquisition by Azad Moopen Mandayapurath and PACs

What Aster DM Healthcare announced

On 15 July 2026, Aster DM Healthcare Ltd (BSE: 540975) submitted a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing informs the market that Azad Moopen Mandayapurath – the founder‑promoter of the group – together with persons acting in concert (PACs) have acquired shares in the company, thereby meeting the threshold for a substantial acquisition.

The notice was filed with the Bombay Stock Exchange and is publicly available as a PDF on the BSE portal. No further narrative or financial details were provided in the brief description accompanying the filing.

Parties involved

• Azad Moopen Mandayapurath – Founder and promoter of Aster DM Healthcare.
• Persons Acting in Concert (PACs) – Individuals or entities that, in accordance with SEBI guidelines, are deemed to act together with the promoter for the purpose of share acquisition.

The filing does not name the specific PACs nor disclose the relationship among them.

Regulatory context

Regulation 29(2) requires any person or group of persons acting in concert to disclose to the stock exchange when their shareholding crosses the 5 % threshold (or any subsequent increase of 1 % thereafter). The purpose is to ensure transparency for investors and to monitor potential changes in control.

Aster DM Healthcare’s filing satisfies this statutory obligation, making the acquisition public and allowing shareholders to assess any shift in ownership dynamics.

Key facts at a glance

Why this matters for investors

The disclosure signals that a key promoter and associated parties have increased their stake, which may affect voting power and strategic direction. While the exact size of the acquisition is not provided, the requirement to file under Reg 29(2) confirms that the holding crossed the materiality threshold defined by SEBI. Investors can now monitor subsequent filings for any further changes or for details on the exact share count, which may be disclosed in later periodic reports.

Conclusion

Aster DM Healthcare has complied with SEBI’s substantial acquisition reporting rules by filing a Reg 29(2) notice on 15 July 2026, indicating that promoter Azad Moopen Mandayapurath and persons acting in concert have acquired shares above the regulatory threshold. The filing does not reveal the precise number of shares or percentage held, and further details may emerge in future disclosures.